Instem plc Completion of the Acquisition of Leadscope (6225T)
15 Noviembre 2019 - 7:10AM
UK Regulatory
TIDMINS
RNS Number : 6225T
Instem plc
15 November 2019
Instem plc
("Instem")
Completion of the Acquisition of Leadscope, Inc.
("Leadscope")
Instem (AIM: INS.L), a leading provider of IT solutions to the
global life sciences market, confirms that further to its
announcement at 7.00 a.m. today, it has now completed the
acquisition of Leadscope.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Richard Lindley
Rachel Hayes
Walbrook Financial PR +44 (0) 20 7933 8000
Nick Rome instem@walbrookpr.com
Tom Cooper
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by over 500 customers worldwide,
including all the largest 25 pharmaceutical companies, enabling
clients to bring life enhancing products to market faster. Instem's
portfolio of software solutions increases client productivity by
automating study-related processes while offering the unique
ability to generate new knowledge through the extraction and
harmonisation of actionable scientific information.
Instem products and services now address aspects of the entire
drug development value chain, from discovery through to market
launch. Management estimate that over 50% of all drugs on the
market have been through some part of Instem's platform at some
stage of their development.
To learn more about Instem solutions and its mission, please
visit www.instem.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FURFFMFDIFUSESF
(END) Dow Jones Newswires
November 15, 2019 08:10 ET (13:10 GMT)
Instem (LSE:INS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Instem (LSE:INS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024